biote Corp. (BTMD) vs Connect Biopharma Holdings Limited (CNTB)

A side-by-side comparison of biote Corp. and Connect Biopharma Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BTMD vs CNTB

growth of $100 · dividends reinvested · last 5y
BTMD -88.9% (-35.5%/yr)CNTB -94.4% (-43.8%/yr)BTMD compounded faster over this window
050100150Start $10020222023202420252026$11$6
BTMD CNTB

BTMD vs CNTB: by the numbers

  • •CNTB is the larger company ($57M vs $51M market cap).
  • •BTMD is profitable (3.19% net margin) while CNTB runs a net loss (-86687.50%).

Metrics side by side

Valuation

MetricBTMDCNTB
P/E ratio9.85N/A
P/S ratio0.28N/A
P/B ratioN/A2.12
EV / EBITDA9.04N/A
FCF yield38.80%N/A

Profitability

MetricBTMDCNTB
Gross margin71.46%100.00%
Operating margin18.50%-90740.62%
Net margin3.19%-86687.50%
ROEN/A-132.16%
ROIC13.63%-136.77%

Growth (annualized)

MetricBTMDCNTB
Revenue CAGR (5Y)10.52%N/A
EPS CAGR (5Y)-25.90%N/A
FCF CAGR (5Y)3.81%N/A
Total return CAGR (5Y)-35.12%-47.22%

Frequently asked

Is BTMD or CNTB more profitable?
BTMD runs the higher net margin — BTMD at 3.19% versus CNTB at -86687.50%.
How have BTMD and CNTB total returns compared?
Over the past 5 years, BTMD delivered -35.12% and CNTB delivered -47.22% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.